Loading…

Efficacy of Triamcinolone Acetonide in Various Acquired Nail Dystrophies

The treatment of nail disorders is currently an unsatisfying exercise. Isolated nail involvement generally does not warrant any systemic therapy. At the same time, treatment is requested because of significant cosmetic and functional handicap. Intralesional triamcinolone acetonide (TA) in the proxim...

Full description

Saved in:
Bibliographic Details
Published in:Journal of dermatology 2005-12, Vol.32 (12), p.963-968
Main Authors: Grover, Chander, Bansal, Shikha, Nanda, Soni, Reddy, Belum Siva Nagi
Format: Article
Language:English
Subjects:
Citations: Items that this one cites
Items that cite this one
Online Access:Get full text
Tags: Add Tag
No Tags, Be the first to tag this record!
cited_by cdi_FETCH-LOGICAL-c3572-f06a50c64178d95e228e6d9dd535d5b188b9d628487fb073a87dadb60a3cc3933
cites cdi_FETCH-LOGICAL-c3572-f06a50c64178d95e228e6d9dd535d5b188b9d628487fb073a87dadb60a3cc3933
container_end_page 968
container_issue 12
container_start_page 963
container_title Journal of dermatology
container_volume 32
creator Grover, Chander
Bansal, Shikha
Nanda, Soni
Reddy, Belum Siva Nagi
description The treatment of nail disorders is currently an unsatisfying exercise. Isolated nail involvement generally does not warrant any systemic therapy. At the same time, treatment is requested because of significant cosmetic and functional handicap. Intralesional triamcinolone acetonide (TA) in the proximal nail fold was evaluated as a treatment modality in 30 patients with twenty‐nail dystrophy, 14 with nail lichen planus, and 6 with nail psoriasis. The number of involved nails varied from 1–20, and 1–10 nails were treated with TA. Fourteen patients discontinued treatment after 1–2 sittings. Out of the 28 patients completing the treatment protocol, 16 showed 75–100% improvement. Predominant side effects included pain, subungual hematoma formation, proximal nail fold hypopigmentation, and atrophy. TA given as a single injection in the proximal nail fold produced good improvement in a significant number of patients completing the treatment protocol. Lower concentrations of TA (5 mg/ml) were quite effective in treating various dermatoses affecting the nail unit. Our technique had fewer side effects than needle‐less injection or multiple injection techniques. Careful attention to injection technique further minimized the side effects associated with the procedure. Sixteen patients completed the six‐month follow‐up and a relapse of nail changes was seen in 10. The relapses were equally responsive to retreatment. TA injected into the proximal nail fold area is a useful, cheap and efficacious treatment for dermatoses affecting the nail unit.
doi_str_mv 10.1111/j.1346-8138.2005.tb00882.x
format article
fullrecord <record><control><sourceid>proquest_cross</sourceid><recordid>TN_cdi_proquest_miscellaneous_70131672</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>70131672</sourcerecordid><originalsourceid>FETCH-LOGICAL-c3572-f06a50c64178d95e228e6d9dd535d5b188b9d628487fb073a87dadb60a3cc3933</originalsourceid><addsrcrecordid>eNqVkE1PwzAMhiMEYmPwF1DFgVtLPpom5cS0DQaa4DK4RmmSikxduyWtWP89LavgjC-27NevrQeAGwQj1MXdJkIkTkKOCI8whDSqMwg5x9HhBIx_R6dgDAmnIY4hG4EL7zcQ4pQieA5GKIkZiikfg-Uiz62Sqg2qPFg7K7fKllVRlSaYKlNXpdUmsGXwIZ2tGt819411Rgev0hbBvPW1q3af1vhLcJbLwpurIU_A--NiPVuGq7en59l0FSpCGQ5zmEgKVRIjxnVKDcbcJDrVmhKqaYY4z1KdYB5zlmeQEcmZljpLoCRKkZSQCbg9-u5ctW-Mr8XWemWKQpame1AwiAhKGO6E90ehcpX3zuRi5-xWulYgKHqOYiN6WKKHJXqOYuAoDt3y9XClybZG_60O4DrBw1HwZQvT_sNavMwXPyX5BksTgqk</addsrcrecordid><sourcetype>Aggregation Database</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>70131672</pqid></control><display><type>article</type><title>Efficacy of Triamcinolone Acetonide in Various Acquired Nail Dystrophies</title><source>Wiley-Blackwell Read &amp; Publish Collection</source><creator>Grover, Chander ; Bansal, Shikha ; Nanda, Soni ; Reddy, Belum Siva Nagi</creator><creatorcontrib>Grover, Chander ; Bansal, Shikha ; Nanda, Soni ; Reddy, Belum Siva Nagi</creatorcontrib><description>The treatment of nail disorders is currently an unsatisfying exercise. Isolated nail involvement generally does not warrant any systemic therapy. At the same time, treatment is requested because of significant cosmetic and functional handicap. Intralesional triamcinolone acetonide (TA) in the proximal nail fold was evaluated as a treatment modality in 30 patients with twenty‐nail dystrophy, 14 with nail lichen planus, and 6 with nail psoriasis. The number of involved nails varied from 1–20, and 1–10 nails were treated with TA. Fourteen patients discontinued treatment after 1–2 sittings. Out of the 28 patients completing the treatment protocol, 16 showed 75–100% improvement. Predominant side effects included pain, subungual hematoma formation, proximal nail fold hypopigmentation, and atrophy. TA given as a single injection in the proximal nail fold produced good improvement in a significant number of patients completing the treatment protocol. Lower concentrations of TA (5 mg/ml) were quite effective in treating various dermatoses affecting the nail unit. Our technique had fewer side effects than needle‐less injection or multiple injection techniques. Careful attention to injection technique further minimized the side effects associated with the procedure. Sixteen patients completed the six‐month follow‐up and a relapse of nail changes was seen in 10. The relapses were equally responsive to retreatment. TA injected into the proximal nail fold area is a useful, cheap and efficacious treatment for dermatoses affecting the nail unit.</description><identifier>ISSN: 0385-2407</identifier><identifier>EISSN: 1346-8138</identifier><identifier>DOI: 10.1111/j.1346-8138.2005.tb00882.x</identifier><identifier>PMID: 16471458</identifier><language>eng</language><publisher>England</publisher><subject>Adolescent ; Adult ; Child ; Dose-Response Relationship, Drug ; Drug Administration Schedule ; Female ; Follow-Up Studies ; Hand Dermatoses - diagnosis ; Hand Dermatoses - drug therapy ; Humans ; inflammatory nail disorders ; Injections, Intralesional ; intralesional ; Lichen Planus - diagnosis ; Lichen Planus - drug therapy ; Male ; Nail Diseases - diagnosis ; Nail Diseases - drug therapy ; Patient Satisfaction ; Prospective Studies ; Psoriasis - diagnosis ; Psoriasis - drug therapy ; Recurrence ; Risk Assessment ; Treatment Outcome ; triamcinolone acetonide ; Triamcinolone Acetonide - therapeutic use</subject><ispartof>Journal of dermatology, 2005-12, Vol.32 (12), p.963-968</ispartof><rights>2005 Japanese Dermatological Association</rights><lds50>peer_reviewed</lds50><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c3572-f06a50c64178d95e228e6d9dd535d5b188b9d628487fb073a87dadb60a3cc3933</citedby><cites>FETCH-LOGICAL-c3572-f06a50c64178d95e228e6d9dd535d5b188b9d628487fb073a87dadb60a3cc3933</cites></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><link.rule.ids>314,780,784,27923,27924</link.rule.ids><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/16471458$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Grover, Chander</creatorcontrib><creatorcontrib>Bansal, Shikha</creatorcontrib><creatorcontrib>Nanda, Soni</creatorcontrib><creatorcontrib>Reddy, Belum Siva Nagi</creatorcontrib><title>Efficacy of Triamcinolone Acetonide in Various Acquired Nail Dystrophies</title><title>Journal of dermatology</title><addtitle>J Dermatol</addtitle><description>The treatment of nail disorders is currently an unsatisfying exercise. Isolated nail involvement generally does not warrant any systemic therapy. At the same time, treatment is requested because of significant cosmetic and functional handicap. Intralesional triamcinolone acetonide (TA) in the proximal nail fold was evaluated as a treatment modality in 30 patients with twenty‐nail dystrophy, 14 with nail lichen planus, and 6 with nail psoriasis. The number of involved nails varied from 1–20, and 1–10 nails were treated with TA. Fourteen patients discontinued treatment after 1–2 sittings. Out of the 28 patients completing the treatment protocol, 16 showed 75–100% improvement. Predominant side effects included pain, subungual hematoma formation, proximal nail fold hypopigmentation, and atrophy. TA given as a single injection in the proximal nail fold produced good improvement in a significant number of patients completing the treatment protocol. Lower concentrations of TA (5 mg/ml) were quite effective in treating various dermatoses affecting the nail unit. Our technique had fewer side effects than needle‐less injection or multiple injection techniques. Careful attention to injection technique further minimized the side effects associated with the procedure. Sixteen patients completed the six‐month follow‐up and a relapse of nail changes was seen in 10. The relapses were equally responsive to retreatment. TA injected into the proximal nail fold area is a useful, cheap and efficacious treatment for dermatoses affecting the nail unit.</description><subject>Adolescent</subject><subject>Adult</subject><subject>Child</subject><subject>Dose-Response Relationship, Drug</subject><subject>Drug Administration Schedule</subject><subject>Female</subject><subject>Follow-Up Studies</subject><subject>Hand Dermatoses - diagnosis</subject><subject>Hand Dermatoses - drug therapy</subject><subject>Humans</subject><subject>inflammatory nail disorders</subject><subject>Injections, Intralesional</subject><subject>intralesional</subject><subject>Lichen Planus - diagnosis</subject><subject>Lichen Planus - drug therapy</subject><subject>Male</subject><subject>Nail Diseases - diagnosis</subject><subject>Nail Diseases - drug therapy</subject><subject>Patient Satisfaction</subject><subject>Prospective Studies</subject><subject>Psoriasis - diagnosis</subject><subject>Psoriasis - drug therapy</subject><subject>Recurrence</subject><subject>Risk Assessment</subject><subject>Treatment Outcome</subject><subject>triamcinolone acetonide</subject><subject>Triamcinolone Acetonide - therapeutic use</subject><issn>0385-2407</issn><issn>1346-8138</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2005</creationdate><recordtype>article</recordtype><recordid>eNqVkE1PwzAMhiMEYmPwF1DFgVtLPpom5cS0DQaa4DK4RmmSikxduyWtWP89LavgjC-27NevrQeAGwQj1MXdJkIkTkKOCI8whDSqMwg5x9HhBIx_R6dgDAmnIY4hG4EL7zcQ4pQieA5GKIkZiikfg-Uiz62Sqg2qPFg7K7fKllVRlSaYKlNXpdUmsGXwIZ2tGt819411Rgev0hbBvPW1q3af1vhLcJbLwpurIU_A--NiPVuGq7en59l0FSpCGQ5zmEgKVRIjxnVKDcbcJDrVmhKqaYY4z1KdYB5zlmeQEcmZljpLoCRKkZSQCbg9-u5ctW-Mr8XWemWKQpame1AwiAhKGO6E90ehcpX3zuRi5-xWulYgKHqOYiN6WKKHJXqOYuAoDt3y9XClybZG_60O4DrBw1HwZQvT_sNavMwXPyX5BksTgqk</recordid><startdate>200512</startdate><enddate>200512</enddate><creator>Grover, Chander</creator><creator>Bansal, Shikha</creator><creator>Nanda, Soni</creator><creator>Reddy, Belum Siva Nagi</creator><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>7X8</scope></search><sort><creationdate>200512</creationdate><title>Efficacy of Triamcinolone Acetonide in Various Acquired Nail Dystrophies</title><author>Grover, Chander ; Bansal, Shikha ; Nanda, Soni ; Reddy, Belum Siva Nagi</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c3572-f06a50c64178d95e228e6d9dd535d5b188b9d628487fb073a87dadb60a3cc3933</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2005</creationdate><topic>Adolescent</topic><topic>Adult</topic><topic>Child</topic><topic>Dose-Response Relationship, Drug</topic><topic>Drug Administration Schedule</topic><topic>Female</topic><topic>Follow-Up Studies</topic><topic>Hand Dermatoses - diagnosis</topic><topic>Hand Dermatoses - drug therapy</topic><topic>Humans</topic><topic>inflammatory nail disorders</topic><topic>Injections, Intralesional</topic><topic>intralesional</topic><topic>Lichen Planus - diagnosis</topic><topic>Lichen Planus - drug therapy</topic><topic>Male</topic><topic>Nail Diseases - diagnosis</topic><topic>Nail Diseases - drug therapy</topic><topic>Patient Satisfaction</topic><topic>Prospective Studies</topic><topic>Psoriasis - diagnosis</topic><topic>Psoriasis - drug therapy</topic><topic>Recurrence</topic><topic>Risk Assessment</topic><topic>Treatment Outcome</topic><topic>triamcinolone acetonide</topic><topic>Triamcinolone Acetonide - therapeutic use</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Grover, Chander</creatorcontrib><creatorcontrib>Bansal, Shikha</creatorcontrib><creatorcontrib>Nanda, Soni</creatorcontrib><creatorcontrib>Reddy, Belum Siva Nagi</creatorcontrib><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>CrossRef</collection><collection>MEDLINE - Academic</collection><jtitle>Journal of dermatology</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Grover, Chander</au><au>Bansal, Shikha</au><au>Nanda, Soni</au><au>Reddy, Belum Siva Nagi</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Efficacy of Triamcinolone Acetonide in Various Acquired Nail Dystrophies</atitle><jtitle>Journal of dermatology</jtitle><addtitle>J Dermatol</addtitle><date>2005-12</date><risdate>2005</risdate><volume>32</volume><issue>12</issue><spage>963</spage><epage>968</epage><pages>963-968</pages><issn>0385-2407</issn><eissn>1346-8138</eissn><abstract>The treatment of nail disorders is currently an unsatisfying exercise. Isolated nail involvement generally does not warrant any systemic therapy. At the same time, treatment is requested because of significant cosmetic and functional handicap. Intralesional triamcinolone acetonide (TA) in the proximal nail fold was evaluated as a treatment modality in 30 patients with twenty‐nail dystrophy, 14 with nail lichen planus, and 6 with nail psoriasis. The number of involved nails varied from 1–20, and 1–10 nails were treated with TA. Fourteen patients discontinued treatment after 1–2 sittings. Out of the 28 patients completing the treatment protocol, 16 showed 75–100% improvement. Predominant side effects included pain, subungual hematoma formation, proximal nail fold hypopigmentation, and atrophy. TA given as a single injection in the proximal nail fold produced good improvement in a significant number of patients completing the treatment protocol. Lower concentrations of TA (5 mg/ml) were quite effective in treating various dermatoses affecting the nail unit. Our technique had fewer side effects than needle‐less injection or multiple injection techniques. Careful attention to injection technique further minimized the side effects associated with the procedure. Sixteen patients completed the six‐month follow‐up and a relapse of nail changes was seen in 10. The relapses were equally responsive to retreatment. TA injected into the proximal nail fold area is a useful, cheap and efficacious treatment for dermatoses affecting the nail unit.</abstract><cop>England</cop><pmid>16471458</pmid><doi>10.1111/j.1346-8138.2005.tb00882.x</doi><tpages>6</tpages></addata></record>
fulltext fulltext
identifier ISSN: 0385-2407
ispartof Journal of dermatology, 2005-12, Vol.32 (12), p.963-968
issn 0385-2407
1346-8138
language eng
recordid cdi_proquest_miscellaneous_70131672
source Wiley-Blackwell Read & Publish Collection
subjects Adolescent
Adult
Child
Dose-Response Relationship, Drug
Drug Administration Schedule
Female
Follow-Up Studies
Hand Dermatoses - diagnosis
Hand Dermatoses - drug therapy
Humans
inflammatory nail disorders
Injections, Intralesional
intralesional
Lichen Planus - diagnosis
Lichen Planus - drug therapy
Male
Nail Diseases - diagnosis
Nail Diseases - drug therapy
Patient Satisfaction
Prospective Studies
Psoriasis - diagnosis
Psoriasis - drug therapy
Recurrence
Risk Assessment
Treatment Outcome
triamcinolone acetonide
Triamcinolone Acetonide - therapeutic use
title Efficacy of Triamcinolone Acetonide in Various Acquired Nail Dystrophies
url http://sfxeu10.hosted.exlibrisgroup.com/loughborough?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-01-08T07%3A55%3A21IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_cross&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Efficacy%20of%20Triamcinolone%20Acetonide%20in%20Various%20Acquired%20Nail%20Dystrophies&rft.jtitle=Journal%20of%20dermatology&rft.au=Grover,%20Chander&rft.date=2005-12&rft.volume=32&rft.issue=12&rft.spage=963&rft.epage=968&rft.pages=963-968&rft.issn=0385-2407&rft.eissn=1346-8138&rft_id=info:doi/10.1111/j.1346-8138.2005.tb00882.x&rft_dat=%3Cproquest_cross%3E70131672%3C/proquest_cross%3E%3Cgrp_id%3Ecdi_FETCH-LOGICAL-c3572-f06a50c64178d95e228e6d9dd535d5b188b9d628487fb073a87dadb60a3cc3933%3C/grp_id%3E%3Coa%3E%3C/oa%3E%3Curl%3E%3C/url%3E&rft_id=info:oai/&rft_pqid=70131672&rft_id=info:pmid/16471458&rfr_iscdi=true